Jane Street
ONCY

Jane Street’s Oncolytics Biotech ONCY Stock Holding History

Jane Street’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$43.3K Buy
42,400
+28,685
+209% +$28.5K ﹤0.01% 11019
2025
Q4 		$14.2K Sell
13,715
-6,615
-33% -$7.15K ﹤0.01% 10784
2025
Q3 		$20.7K Hold
20,330
– – ﹤0.01% 10528
2025
Q2 		$15.5K Buy
+20,330
New +$10.8K ﹤0.01% 9380
2024
Q3 		– Sell
-12,728
Closed -$12.6K – 10165
2024
Q2 		$12.6K Buy
+12,728
New +$13.9K ﹤0.01% 9082
2020
Q1 		– Sell
-14,519
Closed -$69K – 5785
2019
Q4 		$69K Buy
+14,519
New +$16.4K ﹤0.01% 4880

Other funds holding ONCY

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SFP
Sandbox Financial Partners Bethesda, Maryland $356M AUM 19.83% 1-Year Est. Return
SI
Seeds Investor New York $735M AUM 17.54% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
DA
Doliver Advisors Houston, Texas $442M AUM 34.09% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Jane Street's ONCY Position: Q1 2026 in Review

Jane Street increased its Oncolytics Biotech (ONCY) stake by 209% in Q1 2026, buying an estimated $28.5K and bringing the position to 42,400 shares worth $43.3K. The position accounts for ﹤0.01% of the portfolio, ranked #11019.

Jane Street first reported a position in ONCY in Q4 2019 and has held it in 6 quarters since. The position peaked at $69K in Q4 2019. 59 funds tracked by Wall St. Rank hold ONCY as of Q1 2026.

  • Jane Street held 42,400 shares of Oncolytics Biotech worth $43.3K as of Q1 2026.
  • Jane Street bought 28,685 Oncolytics Biotech shares in Q1 2026, an estimated $28.5K.
  • Oncolytics Biotech made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #11019 holding.
  • Jane Street first reported a position in Oncolytics Biotech in Q4 2019 and has held it in 6 quarters since.
  • Jane Street's Oncolytics Biotech position peaked at $69K in Q4 2019.
  • 59 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.